Allina Hlth Cancer Inst Minneapolis — Minneapolis, Minnesota

Allina Hlth Cancer Inst Minneapolis is a clinical research site located in Minneapolis, Minnesota, United States 55407.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Allina Hlth Cancer Inst Minneapolis has participated in 1 clinical trials.

Therapeutic areas: Advanced, Metastatic Breast Cancer.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Allina Hlth Cancer Inst Minneapolis?

Allina Hlth Cancer Inst Minneapolis has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Allina Hlth Cancer Inst Minneapolis conducted?

Allina Hlth Cancer Inst Minneapolis has 1 clinical trials on record. Their work covers Advanced, Metastatic Breast Cancer.

Is Allina Hlth Cancer Inst Minneapolis accredited by Crixeo Health?

Allina Hlth Cancer Inst Minneapolis has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Allina Hlth Cancer Inst Minneapolis?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.